𝔖 Bobbio Scriptorium
✦   LIBER   ✦

0143 First efficacy report for China TAX 619 study: Docetaxel in combination with anthracycline and cyclophosphamide or docetaxel followed by anthracycline and cyclophosphamide in adjuvant therapy for operable node positive breast cancer

✍ Scribed by Z. Shen; G. Liu; Z. Shao; S. Wang; B. Zhang; Z. Jiang; P. He


Book ID
114316280
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
68 KB
Volume
18
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.